These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6801538)

  • 1. Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses.
    Andrews CD; Fernando JC; Curzon G
    Neuropharmacology; 1982 Jan; 21(1):63-8. PubMed ID: 6801538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat.
    Dickinson SL; Andrews CD; Curzon G
    Neuropharmacology; 1984 Apr; 23(4):423-9. PubMed ID: 6728129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour.
    Dickinson SL; Curzon G
    Neuropharmacology; 1983 Jul; 22(7):805-12. PubMed ID: 6225959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion.
    Brundin P; Strecker RE; Londos E; Björklund A
    Exp Brain Res; 1987; 69(1):183-94. PubMed ID: 3125059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ
    Biol Psychiatry; 1986 Mar; 21(3):317-21. PubMed ID: 3081055
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal modulation of nucleus accumbens: behavioral evidence from amphetamine-induced activity profiles.
    Whishaw IQ; Mittleman G
    Behav Neural Biol; 1991 May; 55(3):289-306. PubMed ID: 1905533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine denervation of frontal cortex or nucleus accumbens does not affect ACTH-induced grooming behaviour.
    Dunn AJ; Alpert JE; Iversen SD
    Behav Brain Res; 1984 Jun; 12(3):307-15. PubMed ID: 6087843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization.
    Lynch MR; Carey RJ
    Behav Brain Res; 1989 Feb; 32(1):69-74. PubMed ID: 2495013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
    Boldry R; Chang Y; Miller DD; Uretsky NJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):411-5. PubMed ID: 3780853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats.
    Gerber R; Altar CA; Liebman JM
    Psychopharmacology (Berl); 1988; 94(2):178-82. PubMed ID: 2965396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.